Phosphodiester alkylation with a quinone methide

Journal of Organic Chemistry

Volumn 64, Issue 8, 1999, Pages 2847-2851

  Zhou, Qibing ^a   Turnbull, Kenneth D ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOPHOSPHATE; QUINONE DERIVATIVE; QUINONE METHIDE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; DRUG DESIGN;

EID: 0033574623     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9823745     Document Type: Article

References (43)

1. Peter, M. G. Angew. Chem., Int. Ed. Engl. 1989, 28, 555-570.
2. For reviews on quinone methides, see: (a) Wan, P.; Barker, B.; Diao, L.; Fischer, M.; Shi, Y.; Yang, C. Can. J. Chem. 1996, 74, 465-475.
3. (b) Volod'kin, A. A.; Ershov, V. V. Russ. Chem. Rev. 1988, 57, 336-349.
4. (c) Grünanger, P. in Methoden der Organisch Chemie; Muller, E., Bayer, O., Eds.; Thieme G. Verlag: Stuttgart, 1979; Houben-Weyl, Vol. VII/3b, pp 395-521.
5. (d) Wagner, H. U.; Gompper, R. In The Chemistry of Quinonoid Compound; Patai, S., Ed.; John Wiley & Sons; New York, 1974; Vol. 1, pp 1145-1178.
6. (e) Turner, A. B. Quart. Rev. 1965, 18, 347-360.
7. (a) Moore, H. W.; Czerniak, R. Med. Res. Rev. 1981, 1, 249-280.
8. (b) Moore, H. W. Science 1977, 197, 527-532.
9. Many nucleic acid base alkylation products by o-quinone methide derivatives have been characterized: (a) Ouyang, A.; Skibo, E. B. J. Org. Chem. 1998, 63, 1893-1900.
10. (b) Marques M. M.; Beland, F. A. Carcinogenesis 1997, 18, 1949-1954.
11. (c) Angle, S. R.; Rainer, J. D.; Woytowicz, C. J. Org. Chem. 1997, 62, 5884-5892.
12. (d) Rokita, S. E.; Yang, J.; Pande, P.; Greenberg, W. A. J. Org. Chem. 1997, 62, 3010-3012.
13. (e) Angle, S. R.; Yang, W. J. Org. Chem. 1992, 57, 1092-1097.
14. (f) Angle, S. R.; Yang, W. J. Am. Chem. Soc. 1990, 112, 4524-4528.
15. (g) Egholm, M.; Koch, T. H. J. Am. Chem. Soc. 1989, 111, 8291-8293.
16. (h) Tomasz, M.; Chowdary, D.; Lipman, R.; Shimotakahara, S.; Veiro, D.; Walker, V.; Verdine, G. L. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 6702-6706.
17. Examples of compounds proposed to alkylate and/or cleave DNA through quinone methide intermediates include: (a) Zheng, Q.; Rokita, S. E. J. Org. Chem. 1996, 61, 9080-9081.
18. (b) Taatjes, D.; Gaudiano, G.; Resing, K.; Koch, T. H. J. Med. Chem. 1996, 39, 4135-4138.
19. (c) Mayalarp, S. P.; Hargreaves, R. H. J.; Butler, J.; O'Hare, C. C.; Hartley, J. A. J. Med. Chem. 1996, 39, 531-537.
20. (d) Chatterjee, M.; Rokita, S. E. J. Am. Chem. Soc. 1994, 116, 1690-1697.
21. (e) Boruah, R. C.; Skibo, E. B. J. Med. Chem. 1994, 37, 1625-1631.
22. (f) Nicolau, K. C.; Dai, W.-M. J. Am. Chem. Soc. 1992, 114, 8908-8921.
23. Lewis, M. K.; Yoerg, D. G.; Bolton, J. L.; Thompson, J. A. Chem. Res. Toxicol. 1996, 9, 1368-1374.
24. For an example of a p-quinone methide forming analogue of CC-1065 with potential DNA alkylating abilities, see: Boger, D. L.; Nishi, T.; Teegarden, B. R. J. Org. Chem. 1994, 59, 4943-4949.
25. An elegant aziridinium derivative has been reported to selectively alkylate the DNA phosphodiester backbone: (a) Skibo, E. B.; Schulz, W. G. J. Med. Chem. 1993, 36, 3050-3055.
26. (b) Schulz, W. G.; Nieman, R. A.; Skibo, E. B. Proc. Natl. Acad. Sci. U.S.A 1995, 92, 11854-11858.
27. (c) Skibo, E. B.; Islam, I.; Schulz, W. G.; Zhou, R.; Bess, L.; Boruah, R. SYNLETT 1996, 297-309.
28. (d) Skibo, E. B.; Xing, C. Biochemistry 1998, 37, 15199-15213.
29. Two examples of attempts at DNA phosphodiester alkylation and later retrations: (a) Gohil, R. N.; Roth, A. C.; Day, R. A. Arch. Biochem. Biophys. 1974, 165, 297-312.
30. (b) Bhat, G.; Roth, A. C.; Day, R. A. Biopolymers 1977, 16, 1713-1724.
31. (c) Koole, L. H.; van Genderen, M. H. P.; Buck, H. M. J. Am. Chem. Soc. 1987, 109, 3916-3921.
32. (d) Buck, H. M.; Moody, H. M.; Quaedflieg, P. J. L. M.; Koole, L. H.; van Genderen, M. H. P.; Smit, L.; Jurriaans, S.; Geelen, J. L. M. C.; Goudsmit, J. Science 1990, 250, 125-126.
33. A few synthetic methods have been developed to convert dialkyl phosphate salts into trialkyl phosphates: (a) Ayukawa, H.; Ohuch, S.; Ishikawa, M.; Hata, T. Chem. Lett. 1995, 81.
34. (b) Meier, C.; Habel, L. W.; Balzarini, J.; Clercq, E. D. Liebigs. Ann. 1995, 2203-2208.
35. (c) Neumann, J.-M.; Hervé, M.; Debouzy, J.-C.; Guerra, F. I.; Gouyette, C.; Dupraz, B. Huynh-Dinh, T. J. Am. Chem. Soc. 1989, 111, 4270-4277.
36. (a) Dyall, L. K.; Winstein, S. J. Am. Chem. Soc. 1972, 94, 2196-2199.
37. (b) Filar, L. J.; Winstein, S. Tetrehedron Lett. 1960, 25, 9-25.
38. Rabin, O.; Vigalok, A.; Milstein, D. J. Am. Chem. Soc. 1998, 120, 7119-7120.
39. Koeberg-Telder, A.; Cerfontain, H. J. Chem. Soc., Perkin Trans. 2 1975, 226-229.
40. Complete characterization of a related trapped product will be reported in due course.
41. The Merck Index; Budavari, S., Ed.; Merck &CO: Whitehouse Station, NJ, 1996.
42. a of the dibenzylphosphoric acid was estimated to be 0.71 in water/chloroform mixture: Courtemanche, P.; Merlin, J.-C. Bull. Soc. Chim. Fr. 1967, 10, 3911-3919.
43. The chemical shifts of the benzylic protons of 2 were 4.85 ppm without MsOH, 4.89 ppm with 0.5 equiv of MsOH, 4.93 ppm with 0.8 equiv of MsOH, and 4.96 ppm with 1.0 equiv of MsOH.